Psychedelics Today
by Psychedelics Today
November 16, 2024 5:11 am
Psychedelics Today is the planetary leader in psychedelic education, media, and advocacy. Covering up-to-the-minute developments and diving deep into crucial topics bridging the scientific, academic, philosophical, societal, and cultural, Psychedelics Today is leading the discussion in this rapidly evolving ecosystem.
Recent Episodes
PT565 – From Individualism to Connection: How Psychedelics and Group Therapy Can Heal Our Collective Crisis, with Geoff Bathje, Ph.D.
18 hours agoPT564 – How Safe is Ibogaine Therapy? The Delicate Balance of Risk and Efficacy, with Thomas Feegel
5 days agoPT563 – Why Psychedelic Research is Booming: Current Trends and Hurdles, with Floris Wolswijk
1 week agoPT562 – Ketamine-Assisted Therapy at Work? The Future of Employee Benefits, with Jessica Tracy
2 weeks agoPT561 – Psychedelics Lately – Massachusetts' Question 4 and Updates in Psychedelics and Chronic Pain, with Joe Moore & Kyle Buller
2 weeks agoPT560 – Philosophy and Psychedelics: Can Metaphysics Bring Meaning to Non-Ordinary States?, with Dr. Peter Sjöstedt-Hughes
3 weeks agoPT559 – The Penn Psychedelics Collaborative and the Power of Interdisciplinary Connections, with Taylor Andrews Flatt, PMHNP, Victor Pablo Acero, Ph.D., Jackie Tileston, and Michael Baime, MD
3 weeks agoPT558 – What You Need to Know About Massachusetts' Question 4 and the Natural Psychedelic Substances Act, with Graham Moore and Jamie Morey
4 weeks agoPT557 – Psychedelic Education Through a Healing Justice Lens, with Diana Quinn, ND
4 weeks agoPT556 – The FDA, MDMA, and Public Perception: Was the FDA Fair to Lykos?, with Rick Doblin, Ph.D.
1 month ago